Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

IMMUNOHISTOCHEMISTRY - COMPLEMENTARY REAGENTS - ANVISA Registration 80000230096

Access comprehensive regulatory information for IMMUNOHISTOCHEMISTRY - COMPLEMENTARY REAGENTS in Brazil's medical device market through Pure Global AI's free database. This Risk Class I medical device is registered under ANVISA number 80000230096 and manufactured by AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD.. The registration is held by AGILENT TECHNOLOGIES BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD., BIOCARE MEDICAL, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80000230096
Registration Details
ANVISA Registration Number: 80000230096
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Família de Reagentes Complementares EnVision FLEX (Link)
Risk Class I

Registration Details

80000230096

25351064495202511

03290250000100

Company Information

Singapore
PT: CINGAPURA, REPÚBLICA DA

Dates and Status

Jun 09, 2025

VIGENTE

09/18/2025 19:00:01